Skip to content

ProvodineTM Decreases Hand Contamination

Proposal to Conduct a Study Assessing Whether ProvodineTM Decreases Contamination of Anesthesia Providers' Hands During General Anesthesia Procedures

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04023682
Enrollment
31
Registered
2019-07-17
Start date
2013-12-31
Completion date
2014-11-30
Last updated
2021-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hand Hygiene

Keywords

Hand hygiene, Provodine, Hand contamination

Brief summary

The purpose of this study is to see whether Provodine, an FDA approved product, provides long-lasting protection on the hands of staff who provide anesthesia for patients. If this product does provide long-lasting protection, it could be used for hand hygiene in the operating room and it could help prevent infections after operations. Fifteen anesthesia providers (15 main operating room \[MOR\] and 5 ambulatory surgery center \[ASC\]) who agree to participate will participate in the pre-intervention and intervention periods. During the pre-intervention or baseline period, the investigators will do bag broth cultures of anesthesia providers' hands just before the start of their first case of the day . The participants will then rinse and dry their hands to remove the culture medium. The investigators will also obtain cultures after the first case of the day, and after the second case. During the intervention period (ProvodineTM; usual hand hygiene practice), the investigators obtain hand cultures from the same anesthesia providers at the beginning of the day. The participants will then then do a hand scrub with ProvodineTM. The investigators will obtain a second hand culture at this point and participants will rinse and dry their hands to remove the culture medium and then apply a small amount of ProvodineTM as a hand rub. The investigators will obtain cultures after the first case of the day, and after the second case of the day. If participants are still providing anesthesia to their second case 6 hours after they applied ProvodineTM, the participants will apply a small of ProvodineTM amount as a hand rub at this time. For anesthesia providers in the ASC, the investigators will use the same protocol with the following exception. Because cases are likely to be shorter, the investigators will obtain the final cultures after the last case of the day or after the case that ends closest to 6 hours after ProvodineTM was applied in the morning.

Detailed description

During the pre-intervention or baseline period, the investigators will do bag broth cultures of anesthesia providers' hands just before the start of their first case of the day (n =25). The participants will then rinse and dry their hands to remove the culture medium. The investigators will also obtain cultures after the first case of the day (n = 25), and after the second case (n = 25). During the intervention period (ProvodineTM; usual hand hygiene practice), the investigators obtain hand cultures from the same anesthesia providers at the beginning of the day (n =25). The participants will then then do a hand scrub with ProvodineTM. The investigators will obtain a second hand culture at this point and participants will rinse and dry their hands to remove the culture medium and then apply a small amount of ProvodineTM as a hand rub (n =25). The investigators will obtain cultures after the first case of the day (n = 25), and after the second case of the day (n = 25). If participants are still providing anesthesia to their second case 6 hours after they applied ProvodineTM, the participants will apply a small of ProvodineTM amount as a hand rub at this time. For anesthesia providers in the ASC, the investigators will use the same protocol with the following exception. Because cases are likely to be shorter, the investigators will obtain the final cultures after the last case of the day or after the case that ends closest to 6 hours after ProvodineTM was applied in the morning. The study procedures will occur on two different work days for the participants: one for the control day and one for the intervention day. The study procedures will be done by the end of these two working days. There is no long-term followup.

Interventions

DRUGProvodine Hand Sanitizer

Intervention with Provodine

Sponsors

Microdermis Corporation
CollaboratorINDUSTRY
Sundara Reddy
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Anesthesia providers will serve as their own controls

Eligibility

Sex/Gender
ALL
Age
22 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

\- Must be an anesthesia provider at The University of Iowa Hospitals and Clinics

Exclusion criteria

\- Are not an anesthesia provider at The University of Iowa Hospitals and Clinics

Design outcomes

Primary

MeasureTime frameDescription
Control Period-Count the Number of Baseline Colony Forming Units Cultured From Anesthesiologist's HandsAverage of 1 dayEach subject of the study will serve as their own controls and a comparison will be made between the control phase of the study and the intervention phase of the study. Control portion of the study-usual hand hygiene practice but prior to the anesthesiologist's first case of the day, bag broth cultures will be obtained and the number of CFU's will be counted (T1).
Intervention Period-Count the Number of Baseline Colony Forming Units Cultured From Anesthesiologist's HandsAverage of 1 dayDuring the intervention period, a bag broth culture was performed immediately after the anesthesiologist enter the operating suite. Provodine was applied to the participant's hands, rubbed into his/her skin, washed hands, and dried with a sterile towel. After this a second bag broth culture was obtained.

Secondary

MeasureTime frameDescription
Control Phase-Count and Compare the Number of CFU's After the Second Case of the Day.Average of 1 dayAfter the second surgical case for the day, a bag broth culture was collected (T3) during the control phase from each individual anesthesia provider.
Control Phase-Count and Compare the Number of CFU's After the First Case of the Day.Average of 1 dayAfter the first surgical case for the day, a bag broth culture was collected (T2) during the control phase from each individual anesthesia provider.
Number of Providers/Participants Who Acquired a Pathogen or Commensal During the Day.Average of 1 dayParticipants participated in both the control as well as the interventional phase of this study. The number of unique providers who acquired a pathogen during the course of their day are counted and reported.
Interventional Phase-Count and Compare the Number of CFU's After the Second Case of the Day.Average of 1 dayAfter the second surgical case for the day, a bag broth culture was collected (T3) during the interventional phase from each individual anesthesia provider.
Interventional Phase-Count and Compare the Number of CFU's After the First Case of the Day.Average of 1 dayAfter the first surgical case for the day, a bag broth culture was collected (T2) during the interventional phase from each individual anesthesia provider.

Countries

United States

Participant flow

Participants by arm

ArmCount
Anesthesia Provider Hands
Anesthesia Providers hands cultures with standard hand hygiene Provodine Hand Sanitizer: Intervention with Provodine
31
Total31

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyClinical schedules did not allow continued participation6

Baseline characteristics

CharacteristicAnesthesia Provider Hands
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
31 Participants
Region of Enrollment
United States
31 participants
Sex: Female, Male
Female
11 Participants
Sex: Female, Male
Male
20 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 31
other
Total, other adverse events
0 / 31
serious
Total, serious adverse events
0 / 31

Outcome results

Primary

Control Period-Count the Number of Baseline Colony Forming Units Cultured From Anesthesiologist's Hands

Each subject of the study will serve as their own controls and a comparison will be made between the control phase of the study and the intervention phase of the study. Control portion of the study-usual hand hygiene practice but prior to the anesthesiologist's first case of the day, bag broth cultures will be obtained and the number of CFU's will be counted (T1).

Time frame: Average of 1 day

ArmMeasureValue (MEAN)Dispersion
Anesthesia Provider HandsControl Period-Count the Number of Baseline Colony Forming Units Cultured From Anesthesiologist's Hands589.3 Colony forming unitsStandard Deviation 823.7
Primary

Intervention Period-Count the Number of Baseline Colony Forming Units Cultured From Anesthesiologist's Hands

During the intervention period, a bag broth culture was performed immediately after the anesthesiologist enter the operating suite. Provodine was applied to the participant's hands, rubbed into his/her skin, washed hands, and dried with a sterile towel. After this a second bag broth culture was obtained.

Time frame: Average of 1 day

ArmMeasureValue (MEAN)Dispersion
Anesthesia Provider HandsIntervention Period-Count the Number of Baseline Colony Forming Units Cultured From Anesthesiologist's Hands788.9 Colony forming unitsStandard Deviation 1051.3
Secondary

Control Phase-Count and Compare the Number of CFU's After the First Case of the Day.

After the first surgical case for the day, a bag broth culture was collected (T2) during the control phase from each individual anesthesia provider.

Time frame: Average of 1 day

ArmMeasureValue (MEAN)Dispersion
Anesthesia Provider HandsControl Phase-Count and Compare the Number of CFU's After the First Case of the Day.825.2 Colony forming unitsStandard Deviation 1299.2
Secondary

Control Phase-Count and Compare the Number of CFU's After the Second Case of the Day.

After the second surgical case for the day, a bag broth culture was collected (T3) during the control phase from each individual anesthesia provider.

Time frame: Average of 1 day

ArmMeasureValue (MEAN)Dispersion
Anesthesia Provider HandsControl Phase-Count and Compare the Number of CFU's After the Second Case of the Day.971.2 Colony forming unitsStandard Deviation 1998.3
Secondary

Interventional Phase-Count and Compare the Number of CFU's After the First Case of the Day.

After the first surgical case for the day, a bag broth culture was collected (T2) during the interventional phase from each individual anesthesia provider.

Time frame: Average of 1 day

ArmMeasureValue (MEAN)Dispersion
Anesthesia Provider HandsInterventional Phase-Count and Compare the Number of CFU's After the First Case of the Day.248.9 Colony forming unitsStandard Deviation 709
Secondary

Interventional Phase-Count and Compare the Number of CFU's After the Second Case of the Day.

After the second surgical case for the day, a bag broth culture was collected (T3) during the interventional phase from each individual anesthesia provider.

Time frame: Average of 1 day

ArmMeasureValue (MEAN)Dispersion
Anesthesia Provider HandsInterventional Phase-Count and Compare the Number of CFU's After the Second Case of the Day.382.2 Colony forming unitsStandard Deviation 793.4
Secondary

Number of Providers/Participants Who Acquired a Pathogen or Commensal During the Day.

Participants participated in both the control as well as the interventional phase of this study. The number of unique providers who acquired a pathogen during the course of their day are counted and reported.

Time frame: Average of 1 day

ArmMeasureGroupValue (NUMBER)
Anesthesia Provider HandsNumber of Providers/Participants Who Acquired a Pathogen or Commensal During the Day.Total Number-Unique participants11 participants
Anesthesia Provider HandsNumber of Providers/Participants Who Acquired a Pathogen or Commensal During the Day.Pathogens-Control phase2 participants
Anesthesia Provider HandsNumber of Providers/Participants Who Acquired a Pathogen or Commensal During the Day.Pathogens-Interventional phase3 participants
Anesthesia Provider HandsNumber of Providers/Participants Who Acquired a Pathogen or Commensal During the Day.Commensals-Control phase3 participants
Anesthesia Provider HandsNumber of Providers/Participants Who Acquired a Pathogen or Commensal During the Day.Commensals-Interventional phase3 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026